Skip to content

Clinical trials

Completed Phase 2/3 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Completed Country / region: Japan Clear all

150 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20044
20054
20066
200713
200810
200911
201010
20116
201213
20136
20143
20157
20166
201713
201810
20194
20206
20217
20223
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed150

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Co., Ltd.10
Novartis Pharmaceuticals8
AstraZeneca7
Tanabe Pharma Corporation7
Astellas Pharma Inc6
Eisai Co., Ltd.6
Kyowa Kirin Co., Ltd.6
Takeda6
Abbott5
Bayer5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia8
COVID-195
Diabetes Mellitus, Type 25
Mental Disorders5
Arthritis, Rheumatoid4
Colitis, Ulcerative4
Hemophilia A4
Parkinson Disease4
Anemia, Aplastic3
Crohn Disease3

Trials

Showing 1 to 25 of 150. Each trial links to its page on Pharma Observatory.

50 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.